I agree, PAA should be able to provide a preliminary update, to at least assist shareholders being aware of the potential. A timeline is difficult due to the third party control, however some communication would at least let us know how it is all going.
Organoid Clinical Trial against CoVID-19, page-115
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
-0.010(4.35%) |
Mkt cap ! $86.90M | |||
| Open | High | Low | Value | Volume |
| 23.0¢ | 23.5¢ | 22.0¢ | $111.9K | 495.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 128392 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 48891 | 4 |
View Market Depth
| Last trade - 16.10pm 02/05/2024 (20 minute delay) ? |
|
|||||
|
Last
22.5¢ |
Change
-0.010 ( 2.17 %) |
||||
| Open | High | Low | Volume | ||
| 23.5¢ | 23.5¢ | 22.0¢ | 221305 | ||
| Last updated 15.23pm 02/05/2024 ? | |||||
| PAA (ASX) Chart |